Humacyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Humacyte and other ETFs, options, and stocks.About HUMA
Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E.
CEOLaura E. Niklason
CEOLaura E. Niklason
Employees220
Employees220
HeadquartersDurham, North Carolina
HeadquartersDurham, North Carolina
Founded2004
Founded2004
Employees220
Employees220
HUMA Key Statistics
Market cap188.73M
Market cap188.73M
Price-Earnings ratio-4.08
Price-Earnings ratio-4.08
Dividend yield—
Dividend yield—
Average volume5.62M
Average volume5.62M
High today$1.07
High today$1.07
Low today$0.95
Low today$0.95
Open price$0.98
Open price$0.98
Volume4.30M
Volume4.30M
52 Week high$5.33
52 Week high$5.33
52 Week low$0.91
52 Week low$0.91
Stock Snapshot
With a market cap of 188.73M, Humacyte(HUMA) trades at $1.03. The stock has a price-to-earnings ratio of -4.08.
On 2026-01-05, Humacyte(HUMA) stock moved within a range of $0.95 to $1.07. With shares now at $1.03, the stock is trading +8.4% above its intraday low and -3.7% below the session's peak.
Trading volume for Humacyte(HUMA) stock has reached 4.3M, versus its average volume of 5.62M.
The stock's 52-week range extends from a low of $0.91 to a high of $5.33.
The stock's 52-week range extends from a low of $0.91 to a high of $5.33.
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own HUMA. This list is generated using Robinhood data, and it’s not a recommendation.